New insights into an autoimmune mechanism, pharmacological treatment and relationship between multiple sclerosis and inflammatory bowel disease

Chen Hsing Lin, S. Kadakia, Marianne Frieri

Research output: Contribution to journalReview article

23 Scopus citations

Abstract

Inflammatory bowel disease (IBD) and multiple sclerosis (MS) are autoimmune diseases with a close relationship to their disease pattern and immunologic cascade with considerable morbidity and mortality. This article provides insight of why tumor necrosis factor blockers couldn't work in multiple sclerosis and why interferon-beta doesn't work in inflammatory bowel disease. In this article, we provide a detailed review of the linkage and potential interchangeable medication between IBD and MS in addition to Natalizumab, Trichuris suis egg therapy and vitamin D. Different treatment strategies may have potential in treating both diseases in the future.

Original languageEnglish (US)
Pages (from-to)114-116
Number of pages3
JournalAutoimmunity Reviews
Volume13
Issue number2
DOIs
StatePublished - Feb 2014

Keywords

  • Blood brain barrier
  • Inflammatory bowel disease
  • Multiple sclerosis
  • Th17 cells

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Fingerprint Dive into the research topics of 'New insights into an autoimmune mechanism, pharmacological treatment and relationship between multiple sclerosis and inflammatory bowel disease'. Together they form a unique fingerprint.

Cite this